EBITDA Growth
270.12%
TTM · Period ending:
CARE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported270.12%period ending
Latest reported270.12%period ending
CARE TTM EBITDA YoY % (89.36% → 270.12%)
Year-over-year change
High-resolution chart · PNG
CARE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 270.1158% | |
| 249.4021% | |
| 26.1998% | |
| 88.4772% | |
| 110.8861% | |
| 91.9111% | |
| 8.4503% | |
| -55.1854% | |
| -68.5774% | |
| -71.756% | |
| -48.4081% | |
| 0.4994% | |
| 46.4293% | |
| 83.9135% | |
| 61.6619% | |
| 46.3984% | |
| 256.7925% | |
| 226.9694% | |
| 207.6597% | |
| 198.2051% | |
| -219.1285% | |
| -210.662% | |
| -217.5881% | |
| -218.3627% | |
| 45.1729% | |
| 64.199% | |
| 84.0967% | |
| 1,460.2079% | |
| 1,571.3108% | |
| 224.4302% | |
| 219.4396% | |
| 60.6125% | |
| -123.3359% | |
| -184.74% | |
| -171.9225% | |
| -114.3996% | |
| -89.3374% | |
| -67.5296% | |
| -62.0162% | |
| -22.4861% | |
| -10.4404% | |
| -2.8903% | |
| 2.4796% | |
| 5.9969% | |
| 9.1848% | |
| 18.2244% | |
| 16.9667% | |
| 13.1252% | |
| 3.2452% | |
| -7.7352% | |
| -11.3279% | |
| 1.6805% | |
| 37.4288% | |
| 89.3591% |